Association of RASSF1A genotype and haplotype with the progression of clear cell renal cell carcinoma in Japanese patients

BJU International

Volumn 110, Issue 7, 2012, Pages 1070-1075

  Kawai, Yoshihisa ^a   Sakano, Shigeru ^a   Okayama, Naoko ^a   Suehiro, Yutaka ^a   Matsuyama, Hideyasu ^a   Hinoda, Yuji ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

polymorphism; RASSF1; renal cell carcinoma; survival

Indexed keywords

ALANINE; CYSTEINE; GLYCINE; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; SERINE; RASSF1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; JAPANESE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PRIORITY JOURNAL; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A GENE; RECURRENCE FREE SURVIVAL; SURVIVAL RATE; TUMOR GENE; ASIAN; COHORT ANALYSIS; DISEASE COURSE; GENETICS; GENOTYPE; JAPAN; KIDNEY TUMOR; MIDDLE AGED; MORTALITY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, RENAL CELL; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; JAPAN; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR SUPPRESSOR PROTEINS;

EID: 84871679615     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11143.x     Document Type: Article

References (26)

1. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300
2. Storkel S, Eble JN, Adlakha K, et al,. Classification of renal cell carcinoma: workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997; 80: 987-9
3. Zambrano NR, Lubensky IA, Merino MJ, Linehan WM, Walther MM,. Histopathology and molecular genetics of renal tumors toward unification of a classification system. J Urol 1999; 162: 1246-58
4. Kok K, Naylor SL, Buys CH,. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res 1997; 71: 27-92
5. Thrash-Bingham CA, Greenberg RE, Howard S, et al,. Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes. Proc Natl Acad Sci U S A 1995; 92: 2854-8
6. Gnarra JR, Tory K, Weng Y, et al,. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 1994; 7: 85-90
7. Herman JG, Latif F, Weng Y, et al,. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A 1994; 91: 9700-4
8. Latif F, Tory K, Gnarra J, et al,. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993; 260: 1317-20
9. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP,. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000; 25: 315-9
10. Agathanggelou A, Cooper WN, Latif F,. Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 2005; 65: 3497-508
11. Mathe E,. RASSF1A, the new guardian of mitosis. Nat Genet 2004; 36: 117-8
12. Song MS, Song SJ, Ayad NG, et al,. The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat Cell Biol 2004; 6: 129-37
13. Dallol A, Cooper WN, Al-Mulla F, Agathanggelou A, Maher ER, Latif F,. Depletion of the Ras association domain family 1, isoform A-associated novel microtubule-associated protein, C19ORF5/MAP1S, causes mitotic abnormalities. Cancer Res 2007; 67: 492-500
14. Dallol A, Agathanggelou A, Tommasi S, Pfeifer GP, Maher ER, Latif F,. Involvement of the RASSF1A tumor suppressor gene in controlling cell migration. Cancer Res 2005; 65: 7653-9
15. Tommasi S, Dammann R, Zhang Z, et al,. Tumor susceptibility of Rassf1a knockout mice. Cancer Res 2005; 65: 92-8
16. Kim DH, Kim JS, Ji YI, et al,. Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer. Cancer Res 2003; 63: 3743-6
17. Yanagawa N, Tamura G, Oizumi H, et al,. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers. Lung Cancer 2007; 58: 131-8
18. Muller HM, Widschwendter A, Fiegl H, et al,. DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Res 2003; 63: 7641-5
19. Kawai Y, Sakano S, Suehiro Y, et al,. Methylation level of the RASSF1A promoter is an independent prognostic factor for clear-cell renal cell carcinoma. Ann Oncol 2010; 21: 1612-7
20. Kanzaki H, Hanafusa H, Yamamoto H, et al,. Single nucleotide polymorphism at codon 133 of the RASSF1 gene is preferentially associated with human lung adenocarcinoma risk. Cancer Lett 2006; 238: 128-34
21. Schagdarsurengin U, Seidel C, Ulbrich EJ, Kolbl H, Dittmer J, Dammann R,. A polymorphism at codon 133 of the tumor suppressor RASSF1A is associated with tumorous alteration of the breast. Int J Oncol 2005; 27: 185-91
22. Gao B, Xie XJ, Huang C, et al,. RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers. Cancer Res 2008; 68: 22-5
23. Sung JS, Han SG, Whang YM, et al,. Putative association of the single nucleotide polymorphisms in RASSF1A promoter with Korean lung cancer. Lung Cancer 2008; 61: 301-8
24. Korenaga Y, Naito K, Okayama N, et al,. Association of the BCRP C421A polymorphism with nonpapillary renal cell carcinoma. Int J Cancer 2005; 117: 431-4
25. Donninger H, Vos MD, Clark GJ,. The RASSF1A tumor suppressor. J Cell Sci 2007; 120: 3163-72
26. van der Weyden L, Adams DJ,. The Ras-association domain family (RASSF) members and their role in human tumourigenesis. Biochim Biophys Acta 2007; 1776: 58-85